PESUB15 Incidence of and risk factors for heart failure subtypes in women and men living with HIVPoster exhibitionCardiovascular disease
EPB034 Incidence and risk factors for liver enzyme elevation in HIV-1 infected patients treated for tuberculosis: a secondary analysis of the multi-country ANRS 12300 REFLATE TB2 trialE-posterTuberculosis: Prevention, diagnosis, treatment
EPC089 Incidence and predictors of clinical bone fractures among people with HIV on antiretroviral therapyE-posterEpidemiology of non-AIDS non-communicable diseases (e.g., non-AIDS cancers, CVD)
EPB123 Incidence and disease severity of non-alcoholic fatty liver disease among people living with HIV in ThailandE-posterHepatic complications (e.g., NASH)
OAA0403 In vivo preclinical efficacy of MGD014 and MGD020 (HIV-1 envelope x CD3 DART molecules) and first-in-human phase 1 clinical safety evaluation of MGD014Oral abstract session with live Q&AStrategies to reduce/eliminate viral reservoirs
EPC279 In vivo pharmacokinetics and safety in mice for ultra-long-acting injectable, biodegradable, and removeable in-situ forming implant with cabotegravir for HIV preventionE-posterSexuality, gender and prevention technologies (including condoms, treatment as prevention, medical male circumcision, pre-exposure prophylaxis)
PEMOA29 In vitro release and in vivo pharmacokinetics of antiretroviral drugs from ultra-long-acting polymeric implants: towards better outcomes for HIV prevention and treatmentPoster exhibitionARVs, small molecules and immunomodulating agents - pharmacodynamics and pharmacokinetics
EPC329 Improving viral load testing uptake for HIV infected cohort on antiretroviral therapy (ART) at a rural setting: lessons learnt from Neno district, MalawiE-posterMeasuring and enhancing retention and adherence in HIV prevention programmes
EPD278 Improving viral load suppression rates among children and adolescents living with HIV through strong clinic community collaboration across 5 district in Southwestern UgandaE-posterIntersectional identities and multiple vulnerabilities to HIV and co-infections
EPB208 Improving viral load suppression rate among paediatricpatientson anti-retroviral therapy in Central Province, ZambiaE-posterARV management strategies in paediatric and adolescent populations
1261 - 1270 of 2485 items